Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

EDIT holding history

Editas Medicine, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EDIT overviewAll 13F holders of EDITFull Q2 2026 holdings

Shares (Q2 2026)
1,901,002
Value
$6.16M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of EDIT by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,901,002$6.16M<0.1%−42,891−2.2%ReducedHolders
Q1 20261,943,893$4.80M<0.1%+834,303+75.2%AddedHolders
Q4 20251,109,590$2.27M<0.1%+993,411+855.1%AddedHolders
Q3 2025116,179$403.1K<0.1%+6,066+5.5%AddedHolders
Q2 2025110,113$242.2K<0.1%−349,587−76.0%ReducedHolders
Q1 2025459,700$533.3K<0.1%+280,185+156.1%AddedHolders
Q4 2024179,515$228.0K<0.1%−5,200−2.8%ReducedHolders
Q3 2024184,715$629.9K<0.1%−366,138−66.5%ReducedHolders
Q2 2024550,853$2.57M<0.1%−538,387−49.4%ReducedHolders
Q1 20241,089,240$8.08M<0.1%−98,324−8.3%ReducedHolders
Q4 20231,187,564$12.0M<0.1%+518,819+77.6%AddedHolders
Q3 2023668,745$5.22M<0.1%−117,324−14.9%ReducedHolders
Q2 2023786,069$6.47M<0.1%+287,279+57.6%AddedHolders
Q1 2023498,790$3.62M<0.1%−8,164−1.6%ReducedHolders
Q4 2022506,954$4.50M<0.1%+341,333+206.1%AddedHolders
Q3 2022165,621$2.03M<0.1%−189,204−53.3%ReducedHolders
Q2 2022354,825$4.20M<0.1%−278,086−43.9%ReducedHolders
Q1 2022632,911$12.0M<0.1%+269,778+74.3%AddedHolders
Q4 2021363,133$9.64M<0.1%+231,386+175.6%AddedHolders
Q3 2021131,747$5.41M<0.1%+10,582+8.7%AddedHolders
Q2 2021121,165$6.86M<0.1%−479,643−79.8%ReducedHolders
Q1 2021600,808$25.2M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.